CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Insider Changes in Ownership
- 4 Grant or award Chief People Officer acquired 1,036 shares (grant or award)
- 4 Open-market sale Director sold 6,424 shares at $19.25 ($123,673)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 4 Grant or award Director acquired 17,275 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Scientific Officer acquired 7,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 10,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Growth Officer gave up 2,976 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 2,842 shares (to pay taxes)
- 4 Shares withheld for taxes President, Mental Health gave up 2,666 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 3,641 shares (to pay taxes)
Page 14 of 65 · 1,293 filings